COVID-19 and Cardiovascular Complications

Thursday, April 2, 2020, 12:00 AM - Friday, April 2, 2021, 12:00 AM

Internet Enduring Material Sponsored by Stanford University School of Medicine.

The leading causes of death with COVID-19 are cardiac complications following respiratory failure. Patients with underlying cardiovascular disease are at a higher risk of contracting COVID-19 and face a poor prognosis. This session provides an overview of the biology of COVID-19, the epidemiology and spectrum of cardiac complications, including: myocardial injury, pulmonary hypertension, RV failure, arrythmia and cardiac arrest. A panel of experts discuss clinical manifestations, including symptoms, laboratory studies, radiology and potential drug therapies on the horizon.

  Release Date: April 2, 2020
  Expiration Date: April 2, 2021
  Estimated Time to Complete: 1.30 hours
  CME Credits Offered: 1.50
  Registration Fee: FREE

AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician Participation Credit (1.50 hours)

1. Review available clinical data and reported cardiac complications associated with COVID-19.
2. Review current guidelines and discuss management strategies for COVID-19 associated cardiac complications.
3. Review potential drug toxicities associated with COVID-19.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Credit Designation American Medical Association (AMA) Stanford Medicine designates this Enduring Material for a maximum of 1.50 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. 

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

Reference/Bibliography List

For more resources, please visit:  https://med.stanford.edu/cme/COVID19.html

For CME general questions, please contact 

     Ph: (650)-497-8554
     Email: [email protected]

The Stanford University School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education.   There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.